Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
INFU 
InfuSystems Holdings Inc (INFU)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: INFU (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -30.08% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 111.77M USD | Price to earnings Ratio 48.36 | 1Y Target Price 14.12 |
Price to earnings Ratio 48.36 | 1Y Target Price 14.12 | ||
Volume (30-day avg) 128571 | Beta 1.76 | 52 Weeks Range 5.23 - 9.97 | Updated Date 04/2/2025 |
52 Weeks Range 5.23 - 9.97 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-12 | When Before Market | Estimate 0.06 | Actual 0.0705 |
Profitability
Profit Margin 1.74% | Operating Margin (TTM) 9.5% |
Management Effectiveness
Return on Assets (TTM) 4.53% | Return on Equity (TTM) 4.27% |
Valuation
Trailing PE 48.36 | Forward PE - | Enterprise Value 140506397 | Price to Sales(TTM) 0.83 |
Enterprise Value 140506397 | Price to Sales(TTM) 0.83 | ||
Enterprise Value to Revenue 1.04 | Enterprise Value to EBITDA 7.27 | Shares Outstanding 21009200 | Shares Floating 18156585 |
Shares Outstanding 21009200 | Shares Floating 18156585 | ||
Percent Insiders 5.97 | Percent Institutions 79.35 |
Analyst Ratings
Rating 5 | Target Price 14.12 | Buy - | Strong Buy 4 |
Buy - | Strong Buy 4 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
InfuSystems Holdings Inc
Company Overview
History and Background
InfuSystems Holdings Inc. was founded in 1992. It began as a regional provider of infusion services and has grown into a national provider of infusion therapy services and durable medical equipment to patients in their homes, as well as equipment solutions to healthcare providers.
Core Business Areas
- Infusion Services: Provides infusion therapy services to patients in their homes, focusing on oncology, pain management, and other specialty infusions.
- Durable Medical Equipment (DME): Offers DME rental and sales to healthcare providers and patients. This includes infusion pumps, orthopedics, and other equipment used in post-operative and home healthcare settings.
Leadership and Structure
Richard DiIorio serves as the Chief Executive Officer. The company operates with a functional organizational structure, divided into key areas like operations, sales, finance, and clinical services.
Top Products and Market Share
Key Offerings
- Infusion Pumps: InfuSystems rents and sells infusion pumps, a critical component of its infusion therapy services. The market share for infusion pumps is fragmented with companies like Becton Dickinson (BDX) and Baxter (BAX) also competing. Precise market share data for InfuSystem's pump rentals alone is not publicly available, but the overall US infusion pump market is in the billions of dollars.
- Durable Medical Equipment: Provides a range of DME, including equipment for orthopedics and rehabilitation. Competitors include Medline Industries, Inc. and Cardinal Health (CAH). Specific market share data is not readily available for this category, but the DME market is also substantial.
Market Dynamics
Industry Overview
The infusion therapy and DME markets are driven by an aging population, the increasing prevalence of chronic diseases, and the shift towards home-based healthcare. The industry is highly regulated and competitive.
Positioning
InfuSystems is positioned as a provider of both infusion therapy services and DME, offering integrated solutions for healthcare providers and patients. Its competitive advantages include its national reach, established infrastructure, and expertise in infusion therapy.
Total Addressable Market (TAM)
The combined TAM for infusion therapy and DME is estimated to be tens of billions of dollars. InfuSystems holds a small percentage of this TAM, indicating potential for growth.
Upturn SWOT Analysis
Strengths
- National presence
- Integrated service offerings
- Established infrastructure
- Focus on home-based healthcare
Weaknesses
- Small Market capitalization compared to market leaders
- Reliance on reimbursement rates
- Competition from larger players
- Potential for regulatory changes
Opportunities
- Expanding into new geographic markets
- Developing new service offerings
- Acquiring smaller competitors
- Leveraging technology to improve efficiency
Threats
- Changes in reimbursement policies
- Increased competition
- Economic downturn
- Product liability claims
Competitors and Market Share
Key Competitors
- BAX
- BDX
- CAH
- AMN
Competitive Landscape
InfuSystems faces competition from larger, more diversified healthcare companies. Its advantages include its focus on infusion therapy and DME, as well as its established relationships with healthcare providers.
Major Acquisitions
CIS Healthcare Solutions
- Year: 2020
- Acquisition Price (USD millions): 25
- Strategic Rationale: Expanded InfuSystem's presence in the DME market and broadened its product offerings.
Growth Trajectory and Initiatives
Historical Growth: InfuSystems' growth has been driven by acquisitions and organic expansion in the infusion therapy and DME markets.
Future Projections: Analyst projections unavailable. Requires real-time financial data.
Recent Initiatives: Recent initiatives include focusing on operational efficiencies and expanding service offerings.
Summary
InfuSystems has demonstrated a commitment to the home infusion and DME markets, however it faces stiff competition from larger, more established players in both markets. Its strength lies in its focus and established relationships, but it is vital to enhance operational efficiencies, carefully manage the regulatory landscape, and scale its operations to compete effectively. The small market capitalization poses a challenge for raising capital for expansion. The future success of InfuSystems depends on adapting to evolving industry trends and executing strategic initiatives effectively.
Similar Companies
AMN
AMN Healthcare Services Inc
AMN
AMN Healthcare Services Inc
BAX
Baxter International Inc
BAX
Baxter International Inc
BDX
Becton Dickinson and Company
BDX
Becton Dickinson and Company
CAH
Cardinal Health Inc
CAH
Cardinal Health Inc
Sources and Disclaimers
Data Sources:
- Company filings
- Market research reports
- Analyst estimates
- SEC Filings
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About InfuSystems Holdings Inc
Exchange NYSE MKT | Headquaters Rochester Hills, MI, United States | ||
IPO Launch date 2007-12-27 | CEO & Director Mr. Richard Armand DiIorio | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 502 | Website https://www.infusystem.com |
Full time employees 502 | Website https://www.infusystem.com | ||
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.